Comparing mutation carriers and non-carriers, PIK3CA mutation carriers were significantly more likely to be ER-positive (P = 0.041), PR-positive (P = 0.004) and invasive ductal carcinoma (IDC) (P = 0.002). This evidence concerns the gene PIK3CA and invasive ductal breast carcinoma.